.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Hydrochlorothiazide; propranolol hydrochloride - Generic Drug Details

« Back to Dashboard
Hydrochlorothiazide; propranolol hydrochloride is the generic ingredient in seven branded drugs marketed by Watson Labs, Ani Pharms Inc, Duramed Pharms Barr, Wyeth Pharms Inc, Mylan, Actavis Elizabeth, Ivax Sub Teva Pharms, Wyeth Ayerst, Sandoz, and Warner Chilcott, and is included in twenty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-one drug master file entries for hydrochlorothiazide; propranolol hydrochloride. One supplier is listed for this compound.

Summary for Generic Name: hydrochlorothiazide; propranolol hydrochloride

Tradenames:7
Patents:0
Applicants:10
NDAs:21
Drug Master File Entries: see list31
Suppliers / Packaging: see list1
Formulation / Manufacturing:see details
Drug Prices:see low prices

Pharmacology for Ingredient: hydrochlorothiazide; propranolol hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth
PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; propranolol hydrochloride
TABLET;ORAL070852-001May 15, 1986DISCNNo► subscribe► subscribe
Sandoz
PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; propranolol hydrochloride
TABLET;ORAL071060-001Aug 26, 1987DISCNNo► subscribe► subscribe
Wyeth Pharms Inc
INDERIDE-40/25
hydrochlorothiazide; propranolol hydrochloride
TABLET;ORAL018031-001Approved Prior to Jan 1, 1982DISCNNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: hydrochlorothiazide; propranolol hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Ayerst
INDERIDE LA 80/50
hydrochlorothiazide; propranolol hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL019059-001Jul 3, 19854,138,475► subscribe
Wyeth Ayerst
INDERIDE LA 160/50
hydrochlorothiazide; propranolol hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL019059-003Jul 3, 19854,138,475► subscribe
Wyeth Ayerst
INDERIDE LA 120/50
hydrochlorothiazide; propranolol hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL019059-002Jul 3, 19854,138,475► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc